DK0593562T3 - Topisk præparat indeholdende penciclovir - Google Patents
Topisk præparat indeholdende penciclovirInfo
- Publication number
- DK0593562T3 DK0593562T3 DK92914132T DK92914132T DK0593562T3 DK 0593562 T3 DK0593562 T3 DK 0593562T3 DK 92914132 T DK92914132 T DK 92914132T DK 92914132 T DK92914132 T DK 92914132T DK 0593562 T3 DK0593562 T3 DK 0593562T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation containing
- topical preparation
- penciclovir
- containing penciclovir
- cetomacrogol
- Prior art date
Links
- JNTOCHDNEULJHD-UHFFFAOYSA-N Penciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(CCC(CO)CO)C=N2 JNTOCHDNEULJHD-UHFFFAOYSA-N 0.000 title abstract 2
- 229960001179 penciclovir Drugs 0.000 title abstract 2
- 230000000699 topical effect Effects 0.000 title abstract 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- IQXJCCZJOIKIAD-UHFFFAOYSA-N 1-(2-methoxyethoxy)hexadecane Chemical compound CCCCCCCCCCCCCCCCOCCOC IQXJCCZJOIKIAD-UHFFFAOYSA-N 0.000 abstract 1
- 229950009789 cetomacrogol 1000 Drugs 0.000 abstract 1
- 210000004877 mucosa Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Inks, Pencil-Leads, Or Crayons (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919114939A GB9114939D0 (en) | 1991-07-11 | 1991-07-11 | Pharmaceutical formulation |
| PCT/GB1992/001208 WO1993000905A1 (en) | 1991-07-11 | 1992-07-03 | Tropical composition containing penciclovir |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0593562T3 true DK0593562T3 (da) | 1999-09-27 |
Family
ID=10698164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92914132T DK0593562T3 (da) | 1991-07-11 | 1992-07-03 | Topisk præparat indeholdende penciclovir |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0593562B1 (da) |
| JP (1) | JP2865867B2 (da) |
| KR (1) | KR100245016B1 (da) |
| AT (1) | ATE177638T1 (da) |
| AU (2) | AU2230792A (da) |
| CA (1) | CA2113080C (da) |
| DE (1) | DE69228686T2 (da) |
| DK (1) | DK0593562T3 (da) |
| ES (1) | ES2128353T3 (da) |
| GB (1) | GB9114939D0 (da) |
| GR (1) | GR3029886T3 (da) |
| IE (1) | IE922263A1 (da) |
| MX (1) | MX9204030A (da) |
| NZ (1) | NZ243490A (da) |
| PT (1) | PT100670B (da) |
| TW (1) | TW328049B (da) |
| WO (1) | WO1993000905A1 (da) |
| ZA (1) | ZA925130B (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6124304A (en) * | 1993-10-05 | 2000-09-26 | Smithkline Beecham Plc | Penciclovir for the treatment of zoster associated pain |
| GB9326177D0 (en) * | 1993-12-22 | 1994-02-23 | Smithkline Beecham Plc | Pharmaceuticals |
| IT1287114B1 (it) * | 1996-10-31 | 1998-08-04 | Recordati Chem Pharm | Composizioni farmaceutiche antierpetiche per applicatori topici, contenenti aciclovir |
| US7223387B2 (en) | 1998-11-18 | 2007-05-29 | Medivir Ab | Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester |
| GB9828620D0 (en) * | 1998-12-23 | 1999-02-17 | Glaxo Group Ltd | Medicaments |
| CN109481674A (zh) * | 2018-11-14 | 2019-03-19 | 大连亚维药业有限公司 | 一种生物无菌乳膏药物的生产方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8917959D0 (en) * | 1989-08-05 | 1989-09-20 | Beecham Group Plc | Pharmaceutical formulation |
| GB9001886D0 (en) * | 1990-01-26 | 1990-03-28 | Beecham Group Plc | Pharmaceutical formulation |
-
1991
- 1991-07-11 GB GB919114939A patent/GB9114939D0/en active Pending
-
1992
- 1992-07-03 DE DE69228686T patent/DE69228686T2/de not_active Expired - Lifetime
- 1992-07-03 EP EP92914132A patent/EP0593562B1/en not_active Expired - Lifetime
- 1992-07-03 ES ES92914132T patent/ES2128353T3/es not_active Expired - Lifetime
- 1992-07-03 DK DK92914132T patent/DK0593562T3/da active
- 1992-07-03 JP JP5502081A patent/JP2865867B2/ja not_active Expired - Lifetime
- 1992-07-03 CA CA002113080A patent/CA2113080C/en not_active Expired - Lifetime
- 1992-07-03 KR KR1019940700069A patent/KR100245016B1/ko not_active Expired - Lifetime
- 1992-07-03 WO PCT/GB1992/001208 patent/WO1993000905A1/en not_active Ceased
- 1992-07-03 AU AU22307/92A patent/AU2230792A/en not_active Abandoned
- 1992-07-03 AT AT92914132T patent/ATE177638T1/de active
- 1992-07-09 PT PT100670A patent/PT100670B/pt not_active IP Right Cessation
- 1992-07-09 MX MX9204030A patent/MX9204030A/es active IP Right Grant
- 1992-07-09 ZA ZA925130A patent/ZA925130B/xx unknown
- 1992-07-09 NZ NZ243490A patent/NZ243490A/en not_active IP Right Cessation
- 1992-07-10 IE IE226392A patent/IE922263A1/en not_active IP Right Cessation
- 1992-08-12 TW TW080101931A02A patent/TW328049B/zh not_active IP Right Cessation
-
1995
- 1995-12-14 AU AU40401/95A patent/AU698847B2/en not_active Expired
-
1999
- 1999-04-05 GR GR990400976T patent/GR3029886T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE177638T1 (de) | 1999-04-15 |
| MX9204030A (es) | 1993-02-01 |
| ES2128353T3 (es) | 1999-05-16 |
| CA2113080A1 (en) | 1993-01-21 |
| CA2113080C (en) | 2003-02-25 |
| DE69228686D1 (de) | 1999-04-22 |
| AU2230792A (en) | 1993-02-11 |
| KR100245016B1 (ko) | 2000-03-02 |
| DE69228686T2 (de) | 1999-09-09 |
| IE922263A1 (en) | 1993-01-13 |
| ZA925130B (en) | 1993-05-05 |
| EP0593562A1 (en) | 1994-04-27 |
| PT100670A (pt) | 1993-10-29 |
| JPH06508845A (ja) | 1994-10-06 |
| HK1012242A1 (en) | 1999-07-30 |
| NZ243490A (en) | 1995-03-28 |
| WO1993000905A1 (en) | 1993-01-21 |
| GB9114939D0 (en) | 1991-08-28 |
| AU4040195A (en) | 1996-02-22 |
| JP2865867B2 (ja) | 1999-03-08 |
| GR3029886T3 (en) | 1999-07-30 |
| PT100670B (pt) | 1999-07-30 |
| AU698847B2 (en) | 1998-11-12 |
| TW328049B (en) | 1998-03-11 |
| EP0593562B1 (en) | 1999-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE8504945L (sv) | Farmaceutiska kompositioner innehallande antracyklinglykosider | |
| ITBO910476A0 (it) | -formulazioni farmeceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali. | |
| NO992638L (no) | Gelformulering for topisk legemiddellevering | |
| CA2293470A1 (en) | Benzimidazole derivatives | |
| ES2179040T3 (es) | Utilizacion de 5-fluoro-2'-desoxi-3'-tiacitidina para el tratamiento de la hepatitis b. | |
| FI875272L (fi) | Baerarloesningsmedelssystem i tvao fas. | |
| ITRM920270A0 (it) | Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale. | |
| NO943837D0 (no) | Terapeutisk aktive derivater av 1-naftylpyrazol-3-karboksamider, fremstilling av slike derivater, samt farmasöytiske preparater | |
| MX9200728A (es) | Formulacion farmaceutica adaptada para administracformulacion farmaceutica adaptada para administracion topica, para desordenes en la piel. ion topica, para desordenes en la piel. | |
| ES2044843T3 (es) | Uso de antibioticos de quinolona y naftiridina en la preparacion de medicamentos oftalmicos. | |
| DK0593562T3 (da) | Topisk præparat indeholdende penciclovir | |
| MY110074A (en) | Pharmacuetical formulation. | |
| DK0437225T3 (da) | Topiske præparater | |
| ATE5073T1 (de) | 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| KR910004186A (ko) | 제약학적 배합물 | |
| DE68905076D1 (de) | Pharmazeutische zusammensetzung fuer die behandlung von hautwunden. | |
| ES2060440T3 (es) | Derivados de acidos 1,4-dihidropiridin-dicarboxilicos aril-quinolil substituidos, procedimiento para su fabricacion y su uso en medicamentos. | |
| KR970704442A (ko) | 일시적인 병소 허혈에 의해 유발된 재관류 손상을 치료하기 위한 (S)-아데노실-L-메티오닌(SAMe) 및 그의 생리학상 적합한 염의 용도(Use of (S)-Adenosy-L-Methionine(SAMe) and lts Physiologically Compatible Salts for Treating Reperfusion Damage Triggered by Temporary Focal lschaemia) | |
| ATE223700T1 (de) | Ramoplaninhaltige neue injizierbare arzneizubereitungen | |
| SE8802257D0 (sv) | Antimikrobiell komposition | |
| ATE178800T1 (de) | Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung | |
| IT1242000B (it) | Impiego di sali di trometamina in composizioni farmaceutiche a base di calcitonina somministrabili per via nasale in terapia umana. | |
| IT1254361B (it) | Formulazione farmaceutica per uso topico, indicata nel trattamento di infezioni virali della pelle e delle mucose. | |
| FI941707L (fi) | Naftokinoninen käyttö P. carinii -infektioiden hoitoon ja profylaksiaan | |
| MX9203715A (es) | Preparciones para el tratamiento del tejido aloinjertado. |